Pashtoon Kasi: Got to chair an important session on MRD/ctDNA at ASCO24
Pashtoon Kasi shared on LinkedIn:
“Got to chair an important session on MRD/ctDNA across all cancers at the American Society of Clinical Oncology (ASCO) annual conference this year. Very lively discussion. Had to put the chair cap on to make sure there was enough time for everyone and balanced discussion. So much to learn still. But a lot of good progress.”
Source: Pashtoon Kasi/LinkedIn
Pashtoon Kasi is a medical oncologist and researcher at Weill Cornell Medicine and NewYork-Presbyterian Hospital. Within his roles at Weill Cornell Medicine, he holds the positions of Director for Colorectal Cancer Research and Precision Medicine Director for Liquid Biopsy Research at the Englander Institute of Precision Medicine.
His research primarily focuses on “liquid biopsies,” particularly circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs). His scholarly contributions extend to over 100 publications in esteemed peer-reviewed journals.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023